XML 30 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Net Loss Per Share
3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Net Loss Per Share

11. Net loss per share

 

As a result of the Business Combination, the Company has retroactively restated the weighted average shares outstanding prior to February 5, 2021 to give effect to the Conversion Ratio.

 

The following table summarizes the computation of basic and diluted net loss per share attributable to common stockholders of the Company (in thousands, except share and per share amounts):

 

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Net loss attributable to common stockholders

 

$

(19,048

)

 

$

(9,746

)

Weighted average common shares outstanding-basic and diluted

 

 

32,027,161

 

 

 

14,495,972

 

Net loss per share attributable to common stockholders-basic and diluted

 

$

(0.59

)

 

$

(0.67

)

 

The Company’s unvested restricted common shares have been excluded from the computation of basic net loss per share attributable to common stockholders.

 

The Company’s potentially dilutive securities, which include options and unvested restricted stock, have been excluded from the computation of diluted net loss per share attributable to common stockholders as the effect would be to reduce the net loss per share attributable to common stockholders. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Unvested restricted stock

 

 

-

 

 

 

362,282

 

Options to purchase common stock

 

 

5,602,935

 

 

 

1,836,271

 

Warrants to purchase shares of Series A preferred stock (as converted to common stock)

 

 

-

 

 

 

15,257

 

 

 

 

5,602,935

 

 

 

2,213,810